Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Pivotal Therapeutics Inc C.PVO

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s): PVTTF

Pivotal Therapeutics Inc is engaged in the discovery, development and marketing of prescription grade pharmaceuticals for cardiovascular disease and overall health. Its product, VASCAZEN, is applied in the dietary management of Omega-3 deficiency.
Price: $0.19 | Change: $0.00 | % Change: 0.00%
Volume: 0 | Day High/Low: N/A/N/A | 52 Week High/Low: 0.24/0.03
top

Snapshot

Last Traded: April 23, 2014 11:57 Transaction Volume: 0
Open: $0.19 Previous Close: $0.19
Bid: $0.155 Ask: $0.19
Bid Size: 20,000 Ask Size: 23,500
Market Cap: $17.5m Shares Out: 91.9m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • Ton of money

    3 stars

    These guys raised a ton of money recently. That got me curious. It looks like there is no market right now for this stock. They should...

    1.5 stars


  • News on Pivotal Therapeutics

    0 stars

    Pivotal Therapeutics to raise $5 mln through debt financing, $2.7 mln equity raise completed

    1.5 stars


  • News on Pivotal Therapeutics

    0 stars

    Pivotal Therapeutics says Q2 sales grow 27% as Vascazen impresses cardiologists

    1.5 stars


  • Its alive!

    0 stars

    Next stop $5

    1.5 stars


  • good read

    0 stars

    http://www.proactiveinvestors.com/companies/news/44454/omthera-acquisition-highlights-upside-potential-of-pivotal-therapeutics-44454.html

    1.5 stars